Brii Biosciences Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
128
- Stock Symbol
-
02137
- Investments
-
5
- Share Price
-
$0.12
- (As of Wednesday Closing)
Brii Biosciences General Information
Description
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed to developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as CNS diseases, which have public health burdens in China and worldwide. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.
Contact Information
Website
www.briibio.comCorporate Office
- 3rd Floor, Building Number 7, Zhongguancun Dongsheng International Science Park
- Number 1 North Yongtaizhuang Road, Haidian District
- Beijing, 100192
- China
Corporate Office
- 3rd Floor, Building Number 7, Zhongguancun Dongsheng International Science Park
- Number 1 North Yongtaizhuang Road, Haidian District
- Beijing, 100192
- China
Brii Biosciences Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.12 | $0.12 | $0.11 - $0.45 | $88.1M | 730M | 785K | -$0.05 |
Brii Biosciences Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | (287,085) | (169,834) | 198,726 | 2,832,140 |
| Revenue | 0 | 87 | 7,666 | 0 |
| EBITDA | (50,958) | (39,043) | (75,596) | (647,218) |
| Net Income | (36,886) | (24,711) | (71,915) | (644,850) |
| Total Assets | 451,182 | 491,622 | 566,621 | |
| Total Debt | 0 | 445 | 1,834 | 3,391 |
Brii Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Brii Biosciences Comparisons
Industry
Financing
Details
000000
000000
Brii Biosciences Competitors (29)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alphamab Oncology | Formerly VC-backed | Suzhou, China | 000 | 00000 | 000000000 | 00000 |
| Innovent Biologics | Formerly PE-Backed | Suzhou, China | 0000 | 00.000 | 000000000 | 00.000 |
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | 000 | 00000 | 000000&0 | 00000 |
| BeiGene | Formerly PE-Backed | Cambridge, MA | 0000 | 00.000 | 000000&0 | 00.000 |
| Harbour BioMed | Formerly VC-backed | Hong Kong, Hong Kong | 000 | 00000 | 00000000 | 00000 |
Brii Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Brii Biosciences Executive Team (16)
| Name | Title | Board Seat |
|---|---|---|
| Zhi Hong | Co-Founder, Chairman of the Board and Chief Executive Officer | |
| Ankang Li | Chief Financial Officer, Finance & Board Member | |
| Karen Neuendorff | Chief People Officer & Head of Human Recourse | |
| Brian Johns Ph.D | Chief Scientific Officer | |
| Lianhong Xu | Senior Vice President and Head of Medicinal Chemistry |
Brii Biosciences Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ankang Li | Brii Biosciences | Chief Financial Officer, Finance & Board Member | 000 0000 |
| Gregg Alton JD | Self | Board Member | 000 0000 |
| Robert Nelsen | ARCH Venture Partners | Board Member | 000 0000 |
| Taiyin Yang | Self | Board Member | 000 0000 |
| Zhi Hong | Brii Biosciences | Co-Founder, Chairman of the Board and Chief Executive Officer | 000 0000 |
Brii Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Brii Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Brii Biosciences Investments (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| VBI Vaccines (Intellectual Property Rights In BRII-179) | 13-Feb-2024 | 000000000 | Buildings and Property | 000 0000 | |
| Artizan Biosciences | 15-Jun-2022 | 00000 0000 | 000.00 | Drug Discovery | |
| Tengsheng Huachuang | 01-May-2020 | 00000 0000 | Biotechnology | ||
| AN2 Therapeutics | 21-Nov-2019 | 00000 0000 | 0000 | Drug Discovery | |
| Qpex | 23-Jul-2019 | Early Stage VC | Drug Discovery | 000 0000 |
Brii Biosciences ESG
Risk Overview
Risk Rating
Updated April, 27, 2024
21.4 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 16,216
Rank
Percentile
Commercial Services
Industry
00 of 485
Rank
Percentile
Business Support Services
Subindustry
00 of 193
Rank
Percentile
Brii Biosciences Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| AN2 Therapeutics | 21-Nov-2019 | 00000 00000 | 0000 | Completed |
|
| Qpex | 23-Jul-2019 | Early Stage VC | Completed |
Brii Biosciences FAQs
-
When was Brii Biosciences founded?
Brii Biosciences was founded in 2018.
-
Who is the founder of Brii Biosciences?
Zhi Hong is the founder of Brii Biosciences.
-
Who is the CEO of Brii Biosciences?
Zhi Hong is the CEO of Brii Biosciences.
-
Where is Brii Biosciences headquartered?
Brii Biosciences is headquartered in Beijing, China.
-
What is the size of Brii Biosciences?
Brii Biosciences has 128 total employees.
-
What industry is Brii Biosciences in?
Brii Biosciences’s primary industry is Drug Discovery.
-
Is Brii Biosciences a private or public company?
Brii Biosciences is a Public company.
-
What is Brii Biosciences’s stock symbol?
The ticker symbol for Brii Biosciences is 02137.
-
What is the current stock price of Brii Biosciences?
As of 11-Sep-2024 the stock price of Brii Biosciences is $0.12.
-
What is the current market cap of Brii Biosciences?
The current market capitalization of Brii Biosciences is $88.1M.
-
Who are Brii Biosciences’s competitors?
Alphamab Oncology, Innovent Biologics, Dicerna Pharmaceuticals, BeiGene, and Harbour BioMed are some of the 29 competitors of Brii Biosciences.
-
What is Brii Biosciences’s annual earnings per share (EPS)?
Brii Biosciences’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
